Overall, the tumor cells’ autonomously enhanced glycolysis and protein lactylation modification upregulate CCL2 expression through the ENSA-K63la/SRC-pS12/STAT3-pY705 axis, thereby recruiting macrophages. The gene discussed is CCL2; the disease is neoplasm.